Accord Logo

Intended for UK patients and members of the public

PIL- Topiramate Accord Healthcare 25mg, 50mg, 100mg, 200mg Film-coated Tablets: Change history

  • Variation Description:

    • To update sections 4.2, 4.4 and 5.1 of the SPC in line with reference product, Topamax 25, 50, 100, 200mg film-coated tablets (PL 00242/0301-4; MAH: Janssen-Cilag Ltd; dated 16/09/2022). Consequently, the PIL has been updated.

    • Additional updates have been made to the SPC and Label:

    • To update typographical and text formatting in sections 4.1, 4.5, 4.6, 4.7, 4.8, 5.2 and 5.3 of the SPC.

    • To make amendment to the ‘Excipients’ information in section 4.4 of the SPC to be specific for each strength.

    • To update the ATC level name in section 5.1 of the SPC.

    • To update the braille on the cartons for hyphen in line with United English Braille (UEB).

    PIL sections updated – Index, 1, 2, 4, 5 and 6.

    • Changes: (Updated: 13 Mar 2023)

      Variation Description:

      • To update sections 4.2, 4.4 and 5.1 of the SPC in line with reference product, Topamax 25, 50, 100, 200mg film-coated tablets (PL 00242/0301-4; MAH: Janssen-Cilag Ltd; dated 16/09/2022). Consequently, the PIL has been updated.

      • Additional updates have been made to the SPC and Label:

      • To update typographical and text formatting in sections 4.1, 4.5, 4.6, 4.7, 4.8, 5.2 and 5.3 of the SPC.

      • To make amendment to the ‘Excipients’ information in section 4.4 of the SPC to be specific for each strength.

      • To update the ATC level name in section 5.1 of the SPC.

      • To update the braille on the cartons for hyphen in line with United English Braille (UEB).

      PIL sections updated – Index, 1, 2, 4, 5 and 6.

    • Changes: (Updated: 22 Sep 2022)

      initial upload

    View product information as a: